Equity - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jan. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchase program, authorized amount			$ 3,150,000,000
Repurchases of common stock (in shares)	3,700,000
Repurchases of common stock	$ 475,000,000
Stock repurchase program, remaining authorized amount	$ 2,700,000,000
Cash dividends per share (in dollars per share)	$ 0.38	$ 0.33
Aggregate payout	$ 214,000,000	$ 187,000,000
Open Market, Trading Period
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchases of common stock (in shares)	400,000
Repurchases of common stock	$ 50,000,000
Rule 10b5-1 Trading Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Repurchases of common stock (in shares)	3,300,000	0
Repurchases of common stock	$ 425,000,000